BRIEF published on 04/24/2026 at 07:05, 25 days 21 hours ago BB Biotech AG Reports Q1 2026 Interim Results Drug Development Net Loss Investment Portfolio BB Biotech Q1 2026
BRIEF published on 04/24/2026 at 07:05, 25 days 21 hours ago BB Biotech AG publie ses résultats intermédiaires du premier trimestre 2026 Perte Nette Portefeuille D'investissement Développement De Médicaments BB Biotech 1er Trimestre 2026
BRIEF published on 04/24/2026 at 07:05, 25 days 21 hours ago Réalisations et évolutions stratégiques de BB Biotech au premier trimestre 2026 Valeur Nette D'actif Nouveaux Investissements Performance De BB Biotech Repositionnement De Portefeuille Inclusion De Dividendes
BRIEF published on 04/24/2026 at 07:05, 25 days 21 hours ago BB Biotech Q1 2026 Achievements and Strategic Shifts Net Asset Value Portfolio Repositioning New Investments BB Biotech Performance Dividend Inclusion
PRESS RELEASE published on 04/24/2026 at 07:00, 25 days 21 hours ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first quarter of 2026, showing a net loss of CHF 21 mn compared to CHF 241 mn in the same period of 2025 Investment Company BB Biotech AG Interim Report Results Loss
PRESS RELEASE published on 04/24/2026 at 07:00, 25 days 21 hours ago BB Biotech Q1 2026: Share price outperformance, narrowing discount and active portfolio repositioning BB Biotech AG reports Q1 2026 results with share price outperformance, narrowing discount, and active portfolio repositioning. Eleven new investments made in biotech sector Share Price BB Biotech AG Investments Portfolio Repositioning Q1 2026
BRIEF published on 03/19/2026 at 17:45, 2 months ago BB Biotech AG's AGM Approves Proposals and Dividend Annual General Meeting Investment Strategy Board Re-election Dividend Approval BB Biotech
BRIEF published on 03/19/2026 at 17:45, 2 months ago L'assemblée générale annuelle de BB Biotech AG approuve les propositions et le dividende Stratégie D'investissement Assemblée Générale Annuelle Réélection Du Conseil D'administration Approbation Des Dividendes BB Biotech
PRESS RELEASE published on 03/19/2026 at 17:40, 2 months ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.25 per share Shareholders at BB Biotech AG's AGM approve CHF 2.25 dividend per share. Board proposals endorsed. Re-election of board members Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/20/2026 at 07:05, 2 months 27 days ago BB Biotech AG publie son rapport annuel 2025 Proposition De Dividende Augmentation Du Bénéfice Net BB Biotech Secteur De La Biotechnologie Rapport Annuel 2025
Published on 05/20/2026 at 03:21, 52 minutes ago Challenger Assays Extend New Open Pittable Mineralisation
Published on 05/20/2026 at 00:00, 4 hours 13 minutes ago Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Published on 05/19/2026 at 19:45, 8 hours 28 minutes ago Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative
Published on 05/19/2026 at 16:47, 11 hours 26 minutes ago Lithium South Re-Schedules Plan of Arrangement Closing as a Result of Cease Trade Order
Published on 05/19/2026 at 15:15, 12 hours 58 minutes ago Loop Industries Secures Gujarat Government Alignment Supporting First Commercial Deployment and Multi-Phase India Expansion
Published on 05/19/2026 at 21:24, 6 hours 49 minutes ago EQS-Adhoc: ams OSRAM announces the successful pricing of EUR 1 billion 7.250% Senior Notes due 2032, supporting the path to positive Free Cash Flow from 2027 onwards
Published on 05/19/2026 at 19:50, 8 hours 23 minutes ago EQS-Adhoc: fox e-mobility AG: 3 convertible bonds issued
Published on 05/19/2026 at 19:40, 8 hours 33 minutes ago PRC-Saltillo Named to Forbes Accessibility 200 List
Published on 05/19/2026 at 19:05, 9 hours 8 minutes ago Casper Ruud Returns to Stockholm as Bybit EU Expands Across the Nordics
Published on 05/19/2026 at 18:56, 9 hours 17 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/19/2026 at 18:34, 9 hours 38 minutes ago Availability of preparatory documents for the annual general meeting to be held on June 9, 2026
Published on 05/19/2026 at 18:34, 9 hours 38 minutes ago Mise à disposition des documents préparatoires à l’assemblée générale annuelle mixte des actionnaires du 9 juin 2026
Published on 05/19/2026 at 18:30, 9 hours 43 minutes ago TERACT- Communiqué InVivo Group - Retrait obligatoire
